...
首页> 外文期刊>International Biotechnology Laboratory >Helping drive success of pioneering MRSA test
【24h】

Helping drive success of pioneering MRSA test

机译:帮助推动成功的MRSA测试先锋

获取原文
获取原文并翻译 | 示例
           

摘要

Research indicates that hospital-acquired infections such as methicillin resistant Staphylococcus aweus (MRSA) affect around 100,000 people, causing approximately 5,000 deaths and costing the NHS an estimated £1 billion annually in the U.K. MRSA itself contributes towards nearly 1,000 deaths each year in the the UK and an estimated five million MRSA tests are carried out in this country alone. Screening hospital patients and staff for MRSA is one way of reducing the spread of the bacteria. However,these screens are based on culturing the specimen in Petri dishes and can take up to four days to deliver a result. It has long been recognised that a more rapid method of testing would reduce the spread of infection, cut hospital costs and save patients' lives.
机译:研究表明,医院获得性感染(例如耐甲氧西林的葡萄球菌(MRSA))影响约100,000人,造成约5,000人死亡,并且估计每年在英国造成NHS损失10亿英镑.MRSA本身导致每年约有1,000例死亡。仅在这个国家,英国就进行了大约500万次MRSA测试。对医院患者和医务人员进行MRSA筛查是减少细菌传播的一种方法。但是,这些筛选是基于在培养皿中培养标本而进行的,可能需要长达四天的时间才能得出结果。长期以来,人们已经认识到,更快速的测试方法将减少感染的传播,降低医院成本并挽救患者的生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号